Results 171 to 180 of about 8,133 (230)

Melanocyte changes following PUVA therapy

Journal of the American Academy of Dermatology, 1979
The effect of psoralens and long-wave ultraviolet light (PUVA) therapy on human melanocytes was studied at the ultrastructural level. The results demonstrate an increase in the number of melanocytes, a change in their location, and an increase in the size of the melanosomes.
A S, Zelickson, J H, Mottaz, S A, Muller
openaire   +2 more sources

OCULAR COMPLICATIONS OF PUVA THERAPY

Australasian Journal of Dermatology, 1993
SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
J A, See, P, Weller
openaire   +2 more sources

Melanonychia associated with PUVA therapy

Journal of the American Academy of Dermatology, 2003
We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S, Ledbetter, Sylvia, Hsu
openaire   +2 more sources

PUVA therapy in lichen aureus

Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire   +2 more sources

Dose Measurement in PUVA Therapy

Dermatology, 1979
The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire   +2 more sources

PUVA therapy.

American family physician, 1991
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm, J W, Dijkstra, R J, Ferrara, S, Glanz   +3 more
openaire   +1 more source

Onycholysis occurring during PUVA therapy

Clinical and Experimental Dermatology, 1979
Summary A patient with mycosis fungoides developed onycholysis of all finger nails during photo-chemotherapy (PUVA). After shielding of the nails during UVA exposure normal regrowth was observed. Photo-onycholysis has been recognized for many years as a possible sequel to cutaneous photosensitization complicating therapy with ...
openaire   +2 more sources

Leukoderma punctatum following systemic PUVA therapy

International Journal of Dermatology, 2002
A 35‐year‐old woman with vitiligo vulgaris had been treated with psoralen plus UVA (PUVA) therapy for 15 months. She was given 4,5′,8‐trimethylpsoralen (0.6 mg/kg 3 days/week) and UVA exposure (UV 7001 K Waldmann PUVA chamber). She developed repigmentation over more than 50% of the vitiliginous area over a period of 1 year.
Sunil, Dogra, Rajesh, Jain, Devinder, Parsad, Sanjeev, Handa   +3 more
openaire   +2 more sources

Lymphocyte proliferation during PUVA therapy

Archives of Dermatological Research, 1979
The lymphocyte proliferation of 15 psoriatic patients was sutdied after stimulation with tuberculin, trichophytin, varidase, concanavalin A (Con A), and pokeweek mitogen (PMW) during the first and the eighth PUVA treatment, 2 h after oral intake of 8-methoxypsoralen (8-MOP), immediately after UVA-irradiation, and 24 h later.
openaire   +2 more sources

PUVA therapy of diffuse granuloma annulare

Clinical and Experimental Dermatology, 1988
3 cas de granulome annulaire diffus interessant 20 a 40% de la surface corporelle et de duree variable ont ete traites par la PUVAtherapie.
T C, Hindson, J G, Spiro, H, Cochrane
openaire   +2 more sources